Procter & Gamble Health Limited

BSE: 500126 NSE: PGHL
Procter & Gamble Health Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L99999MH1967PLC013726 Incorporated 26 April 1967 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: PGHL · BSE: 500126 Public Limited Company chemicals and materials
Data last updated
Market Cap
₹9,152 Cr
PGHL · NSE
Share Price
₹5,670.50
+2.85% today
Revenue
₹1,567 Cr
FY 2025-26 · +52.3% YoY
EBITDA
₹457 Cr
Margin 29.1%
Net Profit
₹328 Cr
FY 2025-26 · +40.0% YoY
P/E (TTM)
26.9x
P/B 17.1x
ROE
61.6%
ROCE 76.9%
Debt / Equity
0.02
Interest cover 0.1x

About Procter & Gamble Health Limited

Data last updated:

Procter & Gamble Health Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Procter & Gamble Overseas India Bv. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 26 April 1967 and has been in existence for over 59 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L99999MH1967PLC013726. Its GSTIN is 27AAACE2616F1Z2 (Maharashtra). The company holds 26 GST registrations, of which 11 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 500126 and NSE: PGHL.

The company has an authorised share capital of ₹18 Cr and a paid-up capital of ₹16.6 Cr. It was formerly known as Merck Limited and E.Merck (I) P Ltd. It is led by directors including Milind Vasant Thatte (Managing Director) and Shashank Raghupathy Srowthy (Whole-Time Director).

Its last annual general meeting (AGM) was held on 29 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at P & G Plaza Cardinal Gracias Road Chakala Andheri East, Mumbai, Maharashtra, India – 400099.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹1,567.29 Cr, a growth of 52.3% compared to the previous year. For the same year it recorded a net profit of ₹328.3 Cr (net margin 20.9%) and EBITDA of ₹456.66 Cr (EBITDA margin 29.1%). The net worth stands at ₹524.55 Cr (down 2.3% YoY). Total assets are valued at ₹589.99 Cr (up 1.4% YoY).

The company has about 1,420 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Procter & Gamble Health and McKinsey. As per MCA filings, the company has satisfied charges of ₹41 Cr on record. Court records list 148 cases involving the company, including 98 filed by the company and 50 filed against it; 27 cases are pending. The company has 8 deals on record (8 market trades); the latest was in October 2022. Its 9 peer companies in the Chemicals industry (API Manufacturers, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Agrocel Industries Private Limited with revenue of ₹990.54 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pghealthindia.com.

Company details

CIN L99999MH1967PLC013726
Registration Number 013726
Incorporation Date 26 April 1967
ROC Mumbai
Listing Status Listed - Listed on NSE (PGHL); Listed on BSE (500126)
Company Status Active
Date of Last AGM 29 August 2025
Date of Balance Sheet 31 March 2026
Parent Company Procter & Gamble Overseas India Bv
Compliance Status Active Compliant

Name history

Procter & Gamble Health has undergone 2 name changes throughout its history. The company was previously known as Merck Limited, and E.Merck (I) P Ltd. The current legal name is Procter & Gamble Health Limited.

Company NameStatus
Procter & Gamble Health LimitedCurrent
Merck LimitedPrevious
E.Merck (I) P LtdPrevious
Key People
Milind Vasant Thatte Managing Director Shashank Raghupathy Srowthy Whole-Time Director Lokesh Chandak Cfo

Contact details

Procter & Gamble Health Limited's registered office is in Mumbai, Maharashtra. Its website is pghealthindia.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    pghealthindia.com
  • Registered Address
    P & G Plaza Cardinal Gracias Road Chakala Andheri East, Mumbai, Maharashtra, India – 400099
  • Industry
    Chemicals and Materials, Industrial Chemicals

To see the full contact details of Procter & Gamble Health Limited, buy the company report.

Comprehensive company report
Procter & Gamble Health Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Procter & Gamble Health operates two associated brands: Procter & Gamble Health and McKinsey. Each brand links to its own profile.

BrandDescriptionWebsite
Procter & Gamble Health
Manufacturer of OTC, vitamin & mineral supplements, and chemical productspghealthindia.com
McKinsey
Global management consulting is provided to businesses and governments.mckinsey.com

Financials of Procter & Gamble Health Limited

FY 2025-26 filings available

Procter & Gamble Health Limited reported revenue of ₹1,567.29 Cr (up 52.3% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹1,567 Cr
+52.3% YoY
EBITDA
₹457 Cr
+43.4% YoY
Profit After Tax
₹328 Cr
+40.0% YoY
Net Worth
₹525 Cr
-2.3% YoY
Total Assets
₹590 Cr
+1.4% YoY
Total Debt
₹9.29 Cr
+21.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income statement
Revenue1,5671,0291,1511,2301,1141,0091,356
Revenue growth+52.3%--6.4%+10.3%+10.5%-25.6%-
EBITDA457318286325268246315
EBITDA margin+29.1%+30.9%+24.8%+26.4%+24.0%+24.4%+23.3%
Profit before tax450312273314253233355
Net profit328235216229193177256
Net profit margin+21.0%+22.8%+18.7%+18.6%+17.3%+17.6%+18.9%
EPS (₹)196.93188.28121.07138.23115.98106.51102.04
Balance sheet
Total assets590582-----
Net worth525537-----
Total debt9.297.62-----
Cash & bank185189-----
Net working capital305314-----
Cash flow
Cash from operations338169-----
Cash from investing1.269.59-----
Cash from financing(344)(235)-----
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue364370374325339311310313
Revenue growth (YoY)+7.4%+19.1%+20.7%+3.7%+19.3%---
Other income35.684.004.364.954.033.113.963.28
Total expenses264235263205248230186199
EBITDA99.6013611012090.3480.92123114
EBITDA margin+27.4%+36.6%+29.5%+37.0%+26.7%+26.0%+39.8%+36.4%
Depreciation6.026.175.906.085.445.375.555.77
Interest0.140.210.100.120.120.130.150.15
Profit before tax12913310911988.8178.53122111
Tax32.9738.6131.2330.4822.6317.3530.7929.07

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 31 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue364370374325339311310313
Revenue growth (YoY)+7.4%+19.1%+20.7%+3.7%+19.3%---
Other income35.684.004.364.954.033.113.963.28
Total expenses264235263205248230186199
EBITDA99.6013611012090.3480.92123114
EBITDA margin+27.4%+36.6%+29.5%+37.0%+26.7%+26.0%+39.8%+36.4%
Depreciation6.026.175.906.085.445.375.555.77
Interest0.140.210.100.120.120.130.150.15
Profit before tax12913310911988.8178.53122111
Tax32.9738.6131.2330.4822.6317.3530.7929.07
ParticularsFY 2025-26FY 2024-25Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Revenue1,5671,0291,1511,2301,1141,0091,356
Revenue growth+52.3%--6.4%+10.3%+10.5%-25.6%-
Other income17.3410.3515.6318.3913.1918.1068.89
Total expenses1,1117118659058477631,040
Employee cost223142215206168154183
EBITDA457318286325268246315
EBITDA margin+29.1%+30.9%+24.8%+26.4%+24.0%+24.4%+23.3%
Depreciation23.5916.6927.4028.1027.0830.0429.45
Interest0.550.430.720.770.420.800.00
Profit before tax450312273314253233355
Tax12377.2172.3484.7360.8556.48101
Net profit328235216229193177256
Net profit margin+21.0%+22.8%+18.7%+18.6%+17.3%+17.6%+18.9%
EPS (₹)196.93188.28121.07138.23115.98106.51102.04
ParticularsFY 2025-26FY 2024-25Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Equity & liabilities
Share capital16.6016.60-----
Reserves & surplus508520-----
Shareholders' funds (net worth)525537-----
Secured loans0.000.00-----
Unsecured loans9.297.62-----
Total debt9.297.62-----
Total liabilities590582-----
Assets
Gross block236232-----
Net block102116-----
Capital work in progress13.5910.96-----
Investments0.000.00-----
Inventories137109-----
Sundry debtors164145-----
Cash & bank balances185189-----
Loans & advances70.0683.07-----
Total current assets556526-----
Total current liabilities251212-----
Net working capital305314-----
Total assets590582-----
ParticularsFY 2025-26FY 2024-25Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Opening cash182239-----
Net cash from operating activities338169-----
Net cash from investing activities1.269.59-----
Net cash from financing activities(344)(235)-----
Net change in cash(4.87)(56.46)-----
Closing cash185189-----
ParticularsFY 2025-26FY 2024-25Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Growth
Sales growth+52.3%--6.4%+10.3%+10.5%-25.6%-
EBITDA growth+43.4%--12.0%+21.3%+8.8%-22.0%-
PBT growth+8.3%+52.0%-13.0%+24.0%+8.6%-1.4%-73.6%
Net income growth+40.0%--5.8%+18.7%+8.9%-30.9%-
Revenue CAGR (3Y)+9.2%-2.9%+4.5%-3.2%+8.1%+11.1%+9.3%
EBITDA CAGR (3Y)+13.2%+6.5%+5.1%+1.0%+18.4%+39.4%+33.2%
Profitability & leverage
Net income margin+20.9%+22.8%+17.5%+18.7%+17.3%+17.5%+18.7%
Return on capital employed+76.9%+71.8%+39.8%+43.2%+36.0%+27.5%+18.8%
Return on net worth+61.6%+58.1%+31.2%+33.6%+29.2%+22.0%+13.9%
Debt / equity0.020.020.020.010.010.000.00
Long-term debt / equity0.010.010.010.010.000.000.00
Interest cover0.130.140.280.260.170.370.00
Efficiency & per share
Fixed asset turnover6.695.964.634.784.784.754.57
Inventory turnover12.7412.569.439.839.547.997.31
Debtors turnover10.1211.8911.4512.3515.5613.0111.20
EPS (₹)196.93188.28121.07138.23115.98106.51102.04
Dividend per share (₹)205.00125.00260.0095.0052.50130.00230.00
Book value per share (₹)315.99323.47324.24452.34371.38423.92545.99

To see the full year-wise statements and ratios of Procter & Gamble Health Limited, buy the company report.

Board of directors and KMP of Procter & Gamble Health Limited

Procter & Gamble Health Limited currently reports 7 directors and 1 key managerial person. 33 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Sharad Tyagi
Also directs: Iol Chemicals and Pharmaceuticals Limited, 34East Labs Private Limited
Director01 Apr 20251 Years 7 MonthsCurrent
Krishna Sarma
Also directs: Meera Women Weavers Association, Virago Media Private Limited, Mango Care Foundation
Director01 Apr 20251 Years 7 MonthsCurrent
Milind Vasant ThatteManaging Director01 Apr 20188 Years 7 MonthsCurrent
Aalok AgrawalDirector01 Jun 20197 Years 5 MonthsCurrent
Seema SambasivanDirector01 Apr 20233 Years 7 MonthsCurrent
Subramanian Madhavan
Also directs: Multiples Private Equity Fund II LLP, Anthem Biosciences Limited, Eicher Motors Limited and 5 more
Director15 Nov 20214 Years 11 MonthsCurrent
Showing 6 of 8 current directors and KMP. View all directors and KMP

Peer comparison

Procter & Gamble Health Limited is compared with the 9 companies closest to it by revenue in the Chemicals industry (API Manufacturers, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Procter & Gamble Health Limitedthis company₹1,567.29 Cr (FY 2026)₹328.3 Cr20.9%52.3%1,420Mumbai, Maharashtra, India
Agrocel Industries Private Limited₹990.54 Cr (FY 2025)6.0%Bhachau, Gujarat, India
Diversey India Hygiene Private Limited₹977.55 Cr (FY 2025)13.0%Mumbai, Maharashtra, India
Chemspec Chemicals Private Limited₹974.7 Cr (FY 2025)0.0%Navi Mumbai, Maharashtra, India
Snf(India) Private Limited₹972.75 Cr (FY 2025)4.0%Visakhapatnam, Andhra Pradesh, India
Hindprakash Chemicals Private Limited₹947.74 Cr (FY 2024)-2.0%Ahmedabad, Gujarat, India
A.R. Stanchem Pvt. Ltd.₹929.24 Cr (FY 2025)26.0%Kolkata, West Bengal, India
Lee Pharma Limited₹928.7 Cr (FY 2025)2.0%Hyderabad, Telangana, India
Orient Paper and Industries Ltd.₹911.56 Cr (FY 2025)6.0%Bhubaneswar, Odisha, India
Punjab Chemicals and Crop Protection Limited₹901.95 Cr (FY 2025)-4.0%Derabassi, Punjab, India

To see the full peer comparison of Procter & Gamble Health Limited, buy the company report.

Auditor

Procter & Gamble Health Limited is audited by HARIBHAKTI & CO LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
HARIBHAKTI & CO LLPFY 2023103523W/W100048

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 51.80%, foreign institutional investors hold 6.30%, domestic institutional investors hold 12.50% and retail and other public shareholders hold 29.40%.

Promoters: 51.80%DII (Domestic Institutional): 12.50%FII (Foreign Institutional): 6.30%Retail & Others: 29.40%
Sep 2026
QUARTER
51.80% Promoters
12.50% DII (Domestic Institutional)
6.30% FII (Foreign Institutional)
29.40% Retail & Others
Promoter holding - history
Now 51.80% · Sep 2026High 51.80% · Dec 2025Low 51.80% · Dec 2025
50%50.8%51.5%52.3%53%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 51.80%Mar 2026: 51.80%Jun 2026: 51.80%Sep 2026: 51.80%51.80%51.80%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters51.80%51.80%51.80%51.80%
Public48.20%48.20%48.20%48.20%

Charges & borrowings

Open charges
None
Satisfied charges
₹41 Cr
Breakdown by lending institutions
Canara Bank₹41.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Jul 199580013244Canara Bank₹41 CrSatisfied

To see the full charge records of Procter & Gamble Health Limited, buy the company report.

Total charge records: 1 View all charges

Deals & funding

Procter & Gamble Health Limited has 8 deals on record (8 market trades); the latest was in October 2022.

Total deals
8
Market trades
8

Deals on record (5 of 8)

WhenDealAmountParties
Oct 2022Market trade₹20.99 CrBuyer: Ishares Msci India Small-Cap Etf, an individual
Seller: Ishares Core Emerging Markets Mauritius Co, Ishares India Sc Mauritius Company
Sep 2022Market trade₹22.73 CrBuyer: Ishares Msci India Small-Cap Etf, an individual
Seller: Ishares Core Emerging Markets Mauritius Co, Ishares India Sc Mauritius Company
Jan 2014Market trade₹14.08 CrBuyer: Reliance Mutual Fund A/C Reliance Pharma Fund
Seller: American Fund Insurance A/C American Insurance Series Global, Smaller Cap World Fund Inc
Oct 2009Market trade₹26.93 CrBuyer: JMP Securities Private Limited , Hdfc Trustee Co.Ltd A/C Hdfc Mutual Fund-Mip Long Term Plan
Seller: JMP Securities Private Limited
Nov 2005Market trade₹5.5 CrBuyer: Bsma Ltd
Seller: Mackertich Consultancy Services Pvt Ltd

To see the full deal history of Procter & Gamble Health Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Procter & Gamble Health Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Procter & Gamble Health Limited has a workforce of 1,420 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.

Employee count
1,420
Active EPFO establishments
1
Employee growth
4.8%

GST

Procter & Gamble Health has 26 GST registrations: 11 active and 15 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
26
Active
11
Cancelled / inactive
15
GSTINStateStatusRegistered on
27AAACE2616F1Z2MaharashtraActive01 Jul 2017
27AAACE2616F2Z1MaharashtraActive04 Sep 2017
02AAACE2616F1ZEHimachal PradeshActive01 Jul 2017
05AAACE2616F1Z8UttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Procter & Gamble Health Limited, buy the company report.

Recent activity

Procter & Gamble Health Limited has 39 board changes on record since 2007: 8 appointments and 31 cessations. The latest: Shashank Raghupathy Srowthy was appointed as Whole-Time Director on 01 Oct 2025.

Filing
Procter & Gamble Health Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Appointed
Shashank Raghupathy Srowthy was appointed as Whole-Time Director.
AGM
Procter & Gamble Health Limited last Annual general meeting of members was held on 29 Aug 2025 as per latest MCA records.
Appointed
Krishna Sarma was appointed as Director.
Appointed
Sharad Tyagi was appointed as Director.
Ceased
Rani Jadhav Ajit ceased to be Director.
Ceased
Suresh Narsappa Talwar ceased to be Director.
Appointed
Lokesh Chandak was appointed as CFO.
Appointed
Seema Sambasivan was appointed as Director.
Appointed
Subramanian Madhavan was appointed as Director.
Ceased
Elizabeth Eileen Desmond ceased to be Director.
Ceased
Sujay Wasan ceased to be Director.

32 earlier events are in the company report.

News

Frequently asked questions

Procter & Gamble Health is an active public limited company based in Mumbai, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 26 April 1967 (59+ years old) and is registered under CIN L99999MH1967PLC013726. Listed on BSE: 500126 and NSE: PGHL.

Procter & Gamble Health reported revenue of ₹1,567.29 Cr for FY 2025-26 (up 52.3% YoY) based on standalone financials.

Procter & Gamble Health has 8 current directors and KMP:

The latest financial statements of Procter & Gamble Health on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 August 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Procter & Gamble Health is 27AAACE2616F1Z2, registered in Maharashtra. The company has 26 GST registrations in all, of which 11 are active and 15 are cancelled or inactive. Other active GSTINs include 27AAACE2616F2Z1 (Maharashtra), 02AAACE2616F1ZE (Himachal Pradesh), 05AAACE2616F1Z8 (Uttarakhand).

The CIN (Corporate Identification Number) of Procter & Gamble Health is L99999MH1967PLC013726. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Procter & Gamble Health is a listed company as per MCA records. Its shares are listed on both BSE (code: 500126) and NSE (symbol: PGHL).

Procter & Gamble Health has 148 court cases on record: 98 filed by the company and 50 filed against it. 27 are pending. Most are in the high courts.

Procter & Gamble Health was incorporated on 26 April 1967, making it 59+ years old. It is registered with the Registrar of Companies, Mumbai.

Procter & Gamble Health has 8 deals on record (8 market trades); the latest was in October 2022.

The peers of Procter & Gamble Health by revenue are Agrocel Industries Private Limited, Diversey India Hygiene Private Limited, Chemspec Chemicals Private Limited, Snf(India) Private Limited, Hindprakash Chemicals Private Limited and 4 more, all in the Chemicals industry (API Manufacturers, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).